Market Overview

Theramex Chooses IQVIA's Orchestrated Customer Engagement

Share:

Leading women's health company selects IQVIA's OCE technology
solution to transform engagement with healthcare professionals and
improve the value of every client interaction

IQVIA™ (NYSE:IQV), a company dedicated to applying advanced analytics
and technology in healthcare to help clients find better solutions for
patients, and Theramex, an international pharmaceutical company
dedicated to women's health, today announced a global technology
collaboration to integrate IQVIA's market-leading Orchestrated Customer
Engagement (OCE) platform into Theramex's European commercial operations.

OCE seamlessly connects marketing, sales and other functions to generate
a comprehensive, intelligence-driven customer engagement system. Life
sciences clients and their customers immediately benefit from the faster
removal of internal silos, more accurate decision-making through
predictive analytics and machine learning, and optimized performance
across the enterprise.

"As a company dedicated to women's health, Theramex is committed to
enhancing its client engagement model to provide better access to our
expanding portfolio of products," said Anish Mehta, chief executive
officer, Theramex. "We are pleased to engage IQVIA as our technology
partner to support our bold growth ambitions. OCE is breaking new ground
in customer relationship management, and we are excited about how this
innovative platform will advance our customer interactions."

Under the terms of the agreement, Theramex will move its existing
platforms to OCE in 2018 as it expands its women's health portfolio.
Theramex was formed following CVC Capital Partners' February 2018
acquisition of Teva Pharmaceutical Industries' international women's
health business.

"We are delighted Theramex has chosen to adopt this platform ahead of
traditional customer relationship management solutions that offer
limited flexibility and insight," said Alistair Grenfell, president,
North Europe, Middle East, Africa and South Asia, IQVIA. "OCE is a
genuine evolution in the way pharmaceutical companies manage customer
and stakeholder relationships, make better decisions, and improve
productivity.

"Theramex will be able to take full advantage of OCE's advanced
analytics and machine learning to drive clearer understanding of its
customers' needs with simpler, easier work streams across the company."

About Theramex

Theramex is a leading global specialty pharmaceutical company dedicated
to women and their health. We support women at every stage of their
lives by providing a broad portfolio of innovative and established
brands covering contraception, fertility, menopause and osteoporosis.
Our commitment is to listen to and understand our patients, serve their
needs, and offer healthcare solutions to help improve their lives. Our
vision is to be a lifetime partner for women and the healthcare
professionals who treat them by providing innovative, effective and safe
solutions that care for and support women as their healthcare needs
change. For more information, visit www.theramex.com.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics,
technology solutions and contract research services to the life sciences
industry. Formed through the merger of IMS Health and Quintiles, IQVIA
applies human data science — leveraging the analytic rigor and clarity
of data science to the ever-expanding scope of human science — to enable
companies to reimagine and develop new approaches to clinical
development and commercialization, speed innovation and accelerate
improvements in healthcare outcomes. Powered by the IQVIA CORE™, IQVIA
delivers unique and actionable insights at the intersection of
large-scale analytics, transformative technology and extensive domain
expertise, as well as execution capabilities. With more than 55,000
employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The
company uses a wide variety of privacy-enhancing technologies and
safeguards to protect individual privacy while generating and analyzing
the information that helps their customers drive human health outcomes
forward. IQVIA's insights and execution capabilities help biotech,
medical device and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders tap into a
deeper understanding of diseases, human behaviors and scientific
advances, in an effort to advance their path toward cures. To learn
more, visit www.iqvia.com.

Click
here to subscribe to Mobile Alerts for IQVIA.

View Comments and Join the Discussion!